Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Solesence (SLSN) Invested Capital (2016 - 2025)

Historic Invested Capital for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $22.5 million.

  • Solesence's Invested Capital rose 3942.11% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year increase of 3942.11%. This contributed to the annual value of $15.9 million for FY2024, which is 23841.26% up from last year.
  • As of Q3 2025, Solesence's Invested Capital stood at $22.5 million, which was up 3942.11% from $24.3 million recorded in Q2 2025.
  • In the past 5 years, Solesence's Invested Capital registered a high of $24.3 million during Q2 2025, and its lowest value of $4.3 million during Q1 2021.
  • For the 5-year period, Solesence's Invested Capital averaged around $11.6 million, with its median value being $9.9 million (2022).
  • In the last 5 years, Solesence's Invested Capital tumbled by 5255.26% in 2023 and then soared by 26972.94% in 2025.
  • Solesence's Invested Capital (Quarter) stood at $7.5 million in 2021, then surged by 33.03% to $9.9 million in 2022, then plummeted by 52.55% to $4.7 million in 2023, then surged by 238.41% to $15.9 million in 2024, then soared by 41.37% to $22.5 million in 2025.
  • Its Invested Capital stands at $22.5 million for Q3 2025, versus $24.3 million for Q2 2025 and $21.4 million for Q1 2025.